Dirucotide Terminated Phase 3 Trials for Secondary Progressive Multiple Sclerosis (SPMS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00468611Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis